[Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
D001545:Benserazide / Q000008:administration & dosage / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D004338:Drug Combinations; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D002262:Carboxy-Lyases